InsidersTradesSigma
Follow the Marinomed Biotech AG share price and the full insider trade history of the company, a publicly traded company based in Austria. Shares trade on the AT market, under the authority of FMA (OeKB OAM). Operating in the Healthcare & Pharma sector, Marinomed Biotech AG has logged 26 insider filings. Market capitalisation: €9.8m. The latest transaction was filed on 15 April 2026 (Purchase). Among the most active insiders: Brigitte Ederer. The full history is free.
26
Insider Decl.
n/a
Thresholds
€4m
10 ops.
Buy Volume
n/a
n/a
Sell Volume
42Σ signal
Fundamental score
Ranked 4,053 of 28,932 companies
70.7
score / 100
Value57
Quality84
FCF yld-12%
Earn yld·
EV/EBITDA1.1x
ROE·
Gross mgn82%
Net mgn·
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 15 April 2026
Declarations26 total
357 shares@ €14.000.019% mcap1.1% of flowShareISIN ATMARINOMED6FMA:247695
357 shares@ €14.000.019% mcap1.1% of flowShareISIN ATMARINOMED6FMA:247691
1,500 shares@ €14.000.079% mcap50.0% of flowShareISIN ATMARINOMED6FMA:247198
3,521 shares@ €14.000.18% mcap66.1% of flowShareISIN AT0000A3T5H4FMA:247194
3,521 shares@ €14.000.24% mcap39.8% of flowShareISIN AT0000A3T5H4FMA:247192
33,032 shares@ €14.001.73% mcap98.9% of flowShareISIN AT0000A3T5H4FMA:247190
33,032 shares@ €14.001.73% mcap98.9% of flowShareISIN AT0000A3T5H4FMA:247186
7,885 shares@ €14.700.43% mcap100.0% of flowShareISIN ATMARINOMED6FMA:217081
1,500 shares@ €14.000.079% mcap50.0% of flowShareISIN ATMARINOMED6FMA:216982
5,053 shares@ €5.000.095% mcap33.9% of flowShareISIN ATMARINOMED6FMA:204313
5,634.4 shares@ €37.56270.79% mcap0.1% of flowShareVienna Stock Exchange MICISIN ATMARINOMED6FMA:187466
6,320 shares@ €63.201.50% mcap0.2% of flowShareVienna Stock Exchange MICISIN ATMARINOMED6FMA:178676
632,000 shares@ €63.2020.2% of flowShareVienna Stock Exchange MICISIN ATMARINOMED6FMA:178670
1,772,340 shares@ €88.61779.5% of flowShareVienna Stock Exchange MICISIN ATMARINOMED6FMA:166067
16,200 shares@ €90.005.47% mcap50.9% of flowShareOutside a trading venue NewsISIN ATMARINOMED6FMA:165265
18,750 shares@ €75.005.27% mcap49.1% of flowShareOutside a trading venue NewsISIN ATMARINOMED6FMA:149376
25 of 26 declarations
About Marinomed Biotech AG
Marinomed Biotech AG is a biopharmaceutical company focused on developing antiviral treatments and vaccines. It specializes in innovative solutions for viral diseases and respiratory infections.
